Jingzhi Guanxin Oral Liquids Attenuate Atherosclerotic Coronary Heart Disease via Modulating Lipid Metabolism and PPAR-Related Targets

Jingzhi Guanxin Oral Liquids (JZGX), a traditional Chinese medicine formulation prepared from the decoction of five herbs, has been utilized to relieve chest pain with coronary artery disease (CAD). However, the chemical composition and therapeutic mechanisms of JZGX remain obscured. In this researc...

全面介紹

書目詳細資料

Principais autores:	Xinning Wang, Tao Hu, Yuliang Jiang, Yan He, Peibo Li, Wei Peng, Yonggang Wang, Weiwei Su
格式:	Artigo
語言:	Inglês
出版:	MDPI AG 2024-06-01
叢編:	Pharmaceuticals
主題:	Jingzhi Guanxin oral liquids atherosclerotic coronary heart disease network pharmacology metabolomics lipid metabolism PPARs
在線閱讀:	https://www.mdpi.com/1424-8247/17/6/784
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!